Headlines Covid-19 Specialties Trending Feeds Videos

Anaphylaxis After First Dose of the Pfizer-BioNTech COVID-19 Vaccination

posted 15 hours


Mashup Score: 2

JAMA Network - This JAMA Insights review provides clinical details of anaphylactic reactions reported to and verified by the CDC in the first week of use of...

Effect of Vitamin C, Thiamine, and Hydrocortisone on Ventilator- and Vasopressor-Free Days in Patients With Sepsis

posted 15 hours


Mashup Score: 1

JAMA Network - This randomized trial compares the effect of vitamin C, thiamine, and hydrocortisone vs matching placebo on 30-day ventilator- and vasopressor-free days among patients with...

Beyond ADAURA: What’s Right and What’s Wrong With FDA Regulations?

posted 2 days


SoundCloud - Chadi welcomes back Jack West (@JackWestMD), MD, associate clinical professor and medical oncologist, City of Hope Comprehensive Cancer Center, and Nathan Pennell (@n8pennell), MD,...

Journal of Clinical Oncology - PURPOSE Patients with the activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL) historically showed inferior survival with standard rituximab plus cyclophosphamide, doxorubicin,...

Beyond ADAURA: What’s Right and What’s Wrong With FDA Regulations?

posted 15 hours


SoundCloud - Chadi welcomes back Jack West (@JackWestMD), MD, associate clinical professor and medical oncologist, City of Hope Comprehensive Cancer Center, and Nathan Pennell (@n8pennell), MD,...

It’s official: FDA clamps a hold on bluebird’s troubled LentiGlobin program while EMA considers new measures

posted 15 hours


Endpoints News - What started out as a voluntary hold of a critical development program at bluebird bio has gone into an official lockup at the FDA....